Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Income from Continuing Operations (2016 - 2025)

CorMedix has reported Income from Continuing Operations over the past 16 years, most recently at 14020141.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 14020141.0 for Q4 2025, down 56.9% from a year ago — trailing twelve months through Dec 2025 was 163055000.0 (up 14253.43% YoY), and the annual figure for FY2025 was 163055000.0, up 14253.43%.
  • Income from Continuing Operations reached 14020141.0 in Q4 2025 per CRMD's latest filing, down from 108562980.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 108562980.0 in Q3 2025 and bottomed at 14466123.0 in Q1 2024.
  • Median Income from Continuing Operations over the past 5 years was 7408433.0 (2021), compared with a mean of 2923599.0.
  • The largest annual shift saw Income from Continuing Operations plummeted 74.94% in 2023 before it skyrocketed 4009.63% in 2025.
  • Over 5 years, Income from Continuing Operations stood at 9667173.0 in 2021, then increased by 15.08% to 8208951.0 in 2022, then tumbled by 74.94% to 14360822.0 in 2023, then surged by 326.52% to 32530424.0 in 2024, then plummeted by 56.9% to 14020141.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for CRMD at 14020141.0 in Q4 2025, 108562980.0 in Q3 2025, and 19827981.0 in Q2 2025.